Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ORLISTAT vs ORPHENADRINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ORLISTAT vs ORPHENADRINE: Safety Overview

Metric ORLISTAT ORPHENADRINE
Total FAERS Reports 6,498 584
Deaths Reported 31 121
Death Rate 0.5% 20.7%
Hospitalizations 329 159
Average Patient Age 49.0 yrs 47.9 yrs
% Female Patients 83.9% 79.3%
FDA Approval Date Apr 23, 1999 Approved Prior to Jan 1, 1982
Manufacturer H2-Pharma LLC Sandoz Inc
Route ORAL ORAL
Marketing Status Prescription Discontinued